The Information Machine

Google DeepMind AI Co-Clinician Launch · history

Version 8

2026-05-02 21:58 UTC · 292 items

Narrative

The competitive landscape for clinical AI has gained additional resolution in this synthesis cycle, with Glass Health now documented as a YC-backed, early-stage company that raised $5 million[1][2] and positions itself in ambient scribing and clinical decision support[3][4] — a profile that places it firmly in the early-stage tier, far below OpenEvidence's $12 billion valuation now confirmed by Reuters[5] and $210 million in funding. MedCity News introduced the first skeptical analytical voice on OpenEvidence's valuation: a commentary arguing the $12 billion figure is not as shocking as it appears given the platform's demonstrated physician adoption at scale[6]. The Glass Health vs. Abridge comparison page[7] and Clinical AI Report review[8] document Glass Health as competing directly with Abridge on scribing, with CDS as a secondary feature — positioning it as a scribing-first company that has entered the CDS comparison market rather than a dedicated diagnostic consultation platform. A new benchmark headline describes the DeepMind co-clinician as outpacing GPT-5.4[9], introducing OpenAI's most recent model as a named benchmark comparison target alongside physicians — the first such direct OpenAI product comparison in this thread, and evidence that the competitive benchmarking discourse has extended beyond named clinical AI platforms to frontier general-purpose LLMs.

The medical education research thread has become meaningfully more nuanced. The previous synthesis documented a growing literature suggesting AI adoption during training may impair clinical skill acquisition. This cycle introduces a documented counter-perspective: the American Board of Medical Specialties (ABMS) has published that AI may in fact enhance clinical skills and competence[10], a position directly opposed to the PMC systematic review findings established previously. Additional institutional voices have joined the debate: News Medical reports research on how trainees can use AI without losing critical thinking skills[11]; CLIME (University of Washington) published grand rounds on opportunities and risks of AI for precision medical education[12]; The Hospitalist covered curriculum and educational implications of AI[13]; and — most authoritatively — NEJM published on AI-enabled precision-education systems transforming lifelong learning[14], with Dove Medical Press[15] and LifeScience.net[16] documenting additional study coverage. The Peterson Health Technology Institute (PHTI) has separately published on evidence and policy requirements for scaling clinical AI adoption[17], introducing a health technology assessment voice focused on what evidentiary standards should gate large-scale deployment — a framing that bridges the clinical education debate and the scale-vs.-rigor tension previously documented. An arXiv preprint titled 'From Black-Box Confidence to Measurable Trust in Clinical AI'[18] introduces a technical framing not previously in the thread: the argument that clinical AI must move from opaque confidence scores to measurable, auditable trust metrics, directly relevant to the co-clinician's benchmark methodology and EU AI Act high-risk compliance requirements.

Epic's competitive position has sharpened further: Epic has unveiled an 'Agent Factory'[19], a platform capability that extends EHR-native AI agents beyond ambient charting documentation into configurable agent workflows — directly paralleling the dual-agent (Planner + Talker) architecture that DeepMind has positioned as distinctive to the co-clinician. If Epic Agent Factory is confirmed at the scale of Epic's installed EHR base, the architectural distinctiveness of the co-clinician's agent design becomes substantially harder to sustain as a differentiator. Ethan Goh, MD is now confirmed as a named ARISE leader[20], with Digital Health Wire providing secondary coverage of the ARISE State of Clinical AI report[21], adding organizational face and secondary circulation to a report previously documented only by LinkedIn amplifications. Continued social media amplification on May 2[22][23][24][25] — including German-language coverage[25] and a link to Google's drug discovery push nearing human trials[24] — confirms the co-clinician story remains in active international circulation, but the absence of new primary DeepMind statements means the amplification is running on the original April 30 announcement content rather than fresh disclosures.

Timeline

  • 2023: Glass Health raises $5 million in YC-backed seed funding for its AI-powered clinical decision support platform, establishing it as an early-stage competitor in the ambient scribing and CDS market. [1][2][4]
  • 2024-02: Hindustan Times reports Google DeepMind is working on an AI model to help diagnose patients, providing early public evidence the co-clinician initiative was in development at least two years before announcement. [187]
  • 2024-12-05: FDA finalizes recommendations simplifying the approval process for AI-enabled medical devices, providing a forming regulatory pathway for clinical AI systems in the US. [107]
  • 2025-04-11: Harvard Petrie-Flom Center publishes analysis arguing AI and big data are redefining informed consent rules in ways existing frameworks have not yet accommodated. [138]
  • 2026-01: ARISE (Artificial Intelligence Research Initiative in Safety and Effectiveness), led by Ethan Goh MD, publishes the Stanford-Harvard State of Clinical AI Report 2026, providing an institutional baseline assessment of the clinical AI boom and contextualizing the subsequent co-clinician launch as arriving at the documented peak of a multi-year growth curve. [84][86][85][87][88][89][90][20][21]
  • 2026-01-21: OpenEvidence doubles its valuation to $12 billion as physician adoption accelerates, confirmed by Reuters as the highest-valued named competitor in the clinical consultation AI space. [45][5]
  • 2026-02: MedCity News publishes a critical analysis arguing OpenEvidence's $12 billion valuation is unsurprising given its documented physician adoption scale — the first skeptical analytical voice on OpenEvidence's valuation in the thread. [6]
  • 2026-02-06: Epic releases native AI charting for integrated clinical documentation, entering the ambient documentation market as an EHR incumbent. [70]
  • 2026-02-20: Stanford Law School's CodeX publishes analysis arguing that existing healthcare AI disclosure frameworks — including the Mello framework — fail on their own terms when applied to AI in clinical care. [137]
  • 2026-02-27: AMA publishes National Advocacy Update and releases 2026 Physician Survey on Augmented Intelligence showing physician AI use doubled from 2023 to 2026; AMA position: physicians must lead AI tool development. [75][76][77][78][79]
  • 2026-03-10: OpenEvidence announces that AI collaborated with physicians in one million clinical consultations within 24 hours, confirmed via PR Newswire and Newswise press releases; Amazon launches its healthcare AI assistant on its website and app on the same date. [43][49][105][53][57]
  • 2026-04: OpenEvidence raises $210 million at a $3.5 billion valuation and launches DeepConsult, described as 'the first AI agent purpose-built for physicians,' with a dedicated user guide published on the OpenEvidence platform. [46][54][55]
  • 2026-04: Abridge partners with NEJM, JAMA, and UpToDate for AI clinical decision-making and evidence integration, expanding from AI scribe into evidence-backed clinical decision support embedded in the EHR workflow. [60][61][62][63][64][65][66][67][68][69]
  • 2026-04: MedGemma 1.5 technical report published on arXiv and updated to version 4, with detailed coverage on the Google Research blog documenting capabilities including 3D medical imaging interpretation and medical speech-to-text (MedASR). [37][188][189][190][191][38][192][193][194][41][42]
  • 2026-04: Epic unveils Agent Factory, a platform capability extending EHR-native AI agents beyond ambient charting into configurable agent workflows — directly paralleling the dual-agent architecture at the core of the DeepMind co-clinician and intensifying Epic's competition in the AI agent space. [19]
  • 2026-04-30: Google DeepMind publishes AI co-clinician blog post announcing a research initiative built on a 'triadic care' model, a dual-agent (Planner + Talker) architecture, and benchmark results from 98 primary care scenarios and 140-area consultation skill assessment. First Word Health Tech reports the co-clinician outpaces GPT-5.4 in clinical benchmarks. [26][35][40][195][196][197][9]
  • 2026-04-30: On the same day as the co-clinician announcement, Microsoft publishes a global healthcare AI transformation report and Amazon introduces the Amazon One Medical Health AI assistant, fragmenting healthcare AI news coverage across four simultaneous major announcements. [94][102][96]
  • 2026-04-30: DeepMind VP Research Pushmeet Kohli, health AI leader Alan Karthikesalingam, Google Research VP Avinatan Hassidim, and Google DeepMind researcher Joëlle Barral separately publish LinkedIn posts amplifying the initiative and confirming the Included Health partnership. [27][28][29][30][39]
  • 2026-04-30: Simultaneous social media amplification across X/Twitter, LinkedIn, and Reddit; Grok (xAI) publicly comments on demo; discussion spreads to r/whitecoatinvestor and r/OpenAI communities. [171][198][199][200][201][202][203][204][205][206][207][208][209][210][211][212][213][214][215][216][217]
  • 2026-04: Google announces strategic partnership with Included Health for a nationwide randomized study of AI in virtual care, confirmed by multiple sources including Joëlle Barral's LinkedIn post. [31][32][173][34][174][218][39]
  • 2026-05-01: Social media amplification continues globally; YouTube Shorts coverage begins; r/medicalschool Reddit discussion emerges as the first documented medical student engagement with the co-clinician; physician Derya Unutmaz MD amplifies Alan Karthikesalingam's deep-dive analysis on X. [150][151][152][153][40][219][154][155][156][157][139][158][195]
  • 2026-05-02: International social media amplification continues with German-language coverage (KI News Daily) and accounts linking the co-clinician to Google's drug discovery initiative approaching human trials, broadening the co-clinician narrative beyond clinical consultation into pharmaceutical development. [22][23][24][25][220]
  • 2026-05: AMA publishes updated survey data showing more than 80% of physicians now use AI professionally, with ASCO Post and LinkedIn Pulse providing secondary coverage establishing mainstream physician AI adoption as the backdrop for the co-clinician's clinical trial phase. [80][82][83]
  • 2026-05: Medical Economics publishes analysis on AI malpractice law and physician disclosure obligations; MGMA publishes AI governance framework for medical group practices, adding practice management and legal practice voices to the governance discourse. [93][92]
  • 2026-08: (Upcoming) EU AI Act compliance deadline for medtech companies, including AI systems used as safety components in medical devices or direct patient-facing clinical roles — a binding regulatory forcing function for any clinical AI seeking EU market access. [126][128][130][131]

Perspectives

Google DeepMind / Google Research

Measured optimism with concrete deployment action: presents AI co-clinician as a research initiative with strong benchmark results, explicitly notes limitations, frames AI as operating under physician authority. The Included Health partnership, MedGemma 1.5 technical report (now at arXiv v4), and MedASR documentation signal active transition from research publication to structured clinical validation. First Word Health Tech reports the co-clinician outpaces GPT-5.4 in clinical benchmarks.

Evolution: updated: GPT-5.4 now documented as a named benchmark comparison target, extending the benchmarking frame beyond clinical AI platforms to frontier general-purpose LLMs; no new primary DeepMind statements since April 30

[26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][9]

OpenEvidence

Dominant scaled competitor: a $12B valuation confirmed by Reuters, 1 million physician-AI consultations in a single 24-hour period confirmed via PR Newswire and Newswise, $210M in funding, and the launch of DeepConsult — 'the first AI agent purpose-built for physicians.' MedCity News published the first skeptical analytical take on the valuation, arguing it is unsurprising given adoption metrics rather than inflated.

Evolution: reinforced with critical nuance: Reuters confirms the $12B valuation in mainstream financial media; MedCity News introduces the first skeptical-analytical voice, reframing the valuation as earned rather than speculative — a shift from pure enthusiasm to analytical scrutiny that does not challenge the scale metrics

[43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][6][5]

Glass Health

Early-stage YC-backed competitor with $5M in funding, positioning in ambient scribing and clinical decision support — a scribing-first company that has entered the CDS comparison market and maintains a direct comparison page against Abridge. Its funding and scale are orders of magnitude below OpenEvidence, making it a niche rather than primary competitor to the co-clinician.

Evolution: significantly clarified: previously mentioned only as a 'named secondary competitor' in a comparison article; now fully profiled with funding ($5M YC-backed), product focus (ambient scribing + CDS), and direct competitive positioning against Abridge rather than DeepConsult

[8][1][58][7][59][2][3][4][52]

Abridge

Systematically expanding from AI scribe to evidence-backed clinical decision support: NEJM, JAMA, and UpToDate integrations embed clinical evidence directly into the EHR workflow, competing for institutional medical content authority rather than consumer physician adoption.

Evolution: consistent: no new Abridge developments in current items; prior UpToDate partnership documentation holds

[60][61][62][63][64][65][66][67][68][69]

Epic

EHR incumbent aggressively entering AI agent space: February 2026 native AI charting was followed by the unveiling of Agent Factory, a platform capability for configurable AI agent workflows — directly paralleling the Planner + Talker architecture DeepMind has positioned as distinctive to the co-clinician, and extending Epic's AI competition beyond documentation into agent-based clinical reasoning support.

Evolution: significantly updated: Agent Factory extends Epic's AI capabilities beyond documentation into configurable agent workflows, making Epic a more direct architectural competitor to the co-clinician than previously documented

[70][19]

JAMA / medical journal establishment

Institutionally engaged with the evidentiary question and commercially embedded in clinical AI deployment: JAMA continues calling for new AI research, publishing considerations on translating AI to improve care, and maintaining its commercial partnership with Abridge — making journals simultaneous validators, critics, and commercial participants. NEJM separately enters the medical education AI discourse.

Evolution: consistent with new NEJM thread: NEJM's publication on AI-enabled precision-education systems adds the second major medical journal to the medical education AI debate alongside JAMA's ongoing research calls

[60][71][61][62][63][64][65][66][67][68][72][73][74][14]

American Medical Association (AMA)

Institutionally supportive of physician-led AI adoption: updated 2026 survey documents that more than 80% of physicians use AI professionally; AMA's explicit position is that physicians must lead in developing AI tools.

Evolution: consistent: no new AMA developments in current items

[75][76][77][78][79][80][81][82][83]

American Board of Medical Specialties (ABMS)

Counter-perspective on AI and medical training: ABMS has published that AI may enhance rather than impair clinical skills and competence, directly opposing systematic review findings on AI-associated skill degradation and providing physician certification board credibility to the optimistic case for AI in medical training.

Evolution: new voice: first documented institutional position from the body responsible for physician board certification on the training implications of AI — converts the deskilling debate from an emerging concern into a formally contested empirical question

[10]

Peterson Health Technology Institute (PHTI)

Health technology assessment voice focused on evidence and policy requirements before scaling clinical AI adoption — frames the question not as 'will AI help?' but as 'what evidence standard must be met before widespread deployment?', bridging outcomes research and policy in a way distinct from both the AMA's physician-leadership framing and the legal scholars' informed consent focus.

Evolution: new voice: adds a health technology assessment institutional perspective to the evidence debate, distinct from the academic, legal, and professional society voices previously documented

[17]

ARISE / Stanford-Harvard institutional research

The ARISE organization (Artificial Intelligence Research Initiative in Safety and Effectiveness), led by Ethan Goh MD, is confirmed as the institutional home of the State of Clinical AI 2026 report, with Digital Health Wire providing secondary coverage confirming the report's wider circulation.

Evolution: clarified further: Ethan Goh MD now identified as the named ARISE leader and report author; Digital Health Wire secondary coverage confirms the report's reach beyond LinkedIn amplification

[84][85][86][87][88][89][90][91][20][21]

Medical Group Management Association (MGMA)

Governance voice focused on practice administration: MGMA frames AI in medical group practices as a governance challenge requiring rules 'for the humans in the loop' — a practice management framing distinct from both the AMA's physician-leadership stance and legal scholars' informed consent focus.

Evolution: consistent: no new MGMA developments in current items

[92]

Legal practice community (Medical Economics)

Clinically focused legal analysis: Medical Economics frames the AI disclosure question through malpractice liability — whether physicians have an obligation to disclose when AI is used in care — adding a clinical practice risk management angle beyond the academic frameworks of Stanford Law and Harvard Petrie-Flom.

Evolution: consistent: no new Medical Economics developments in current items

[93]

Microsoft

Competing in healthcare AI at global scale: published a healthcare AI transformation report on April 30, 2026 — the same day as DeepMind's co-clinician announcement — documenting AI progress for patients and medical professionals worldwide.

Evolution: consistent: no new Microsoft developments in current items

[94][95][96]

Amazon / incumbent tech competitors

Amazon has formally introduced the Amazon One Medical Health AI assistant and scaled a health AI assistant to all US customers.

Evolution: consistent: no new Amazon developments in current items

[97][98][99][100][101][102][103][104][105]

FDA (US regulatory)

Moving toward streamlined AI medical device approval: December 2024 finalization of simplified approval recommendations signals a forming regulatory pathway for clinical AI. The FDA's SaMD and AI-enabled device frameworks remain the applicable regime but have not been applied to conversational diagnostic AI specifically.

Evolution: consistent: no new FDA developments in current items

[106][107][108][109][110][111]

EU regulatory and legal analysts

Compliance-focused with a concrete August 2026 deadline: EU AI Act Annex III high-risk classification applies to patient-facing clinical AI. A&O Shearman and EU AI Risk publish detailed compliance guidance for high-risk AI systems. At least one industry voice frames early EU compliance as a 'competitive edge' rather than a burden.

Evolution: consistent: no new EU regulatory developments in current items

[112][113][114][115][116][117][118][119][120][121][122][123][124][125][126][127][128][129][130][131]

Legal and bioethics scholars (Stanford Law CodeX, Harvard Petrie-Flom Center)

Critically constructive: Stanford Law argues existing disclosure frameworks fail on their own terms; Harvard Petrie-Flom Center argues AI and big data are redefining informed consent rules in ways existing frameworks have not accommodated.

Evolution: consistent: no new legal/bioethics developments in current items

[132][133][134][135][136][137][138]

Medical student community and medical education research

A growing and now formally contested research literature on medical student AI use: systematic reviews suggest AI adoption may impair clinical skill acquisition, while ABMS argues AI may enhance clinical skills, News Medical covers the critical thinking preservation challenge, CLIME and The Hospitalist address curriculum implications, and NEJM publishes on AI-enabled precision-education systems. The debate has moved from an anecdotal Reddit concern to a multi-institutional, multi-journal empirical dispute.

Evolution: significantly deepened and contested: the previous synthesis documented one-sided risk framing; ABMS counter-perspective, NEJM publication, and multi-institutional educational discourse now make this a formally contested empirical question with high-profile institutional voices on both sides

[139][140][141][142][143][144][145][146][147][148][15][16][149][12][11][10][13][14]

Technical AI trust research community

New technical framing: an arXiv preprint argues that clinical AI systems must move from opaque black-box confidence scores to measurable, auditable trust metrics — a technical governance challenge distinct from regulatory compliance or clinical validation, with direct implications for how benchmark results should be interpreted and what auditability means in practice.

Evolution: new voice: first technical trust measurement framing in the thread; intersects with the co-clinician's benchmark methodology and EU AI Act high-risk auditability requirements

[18]

Physician community (individual practitioners, LinkedIn, X/Twitter)

Early-adopter enthusiasm backed by majority adoption data: continued amplification on May 2 across English and German platforms, with accounts linking the co-clinician to Google's drug discovery push approaching human trials and broadening the narrative beyond clinical consultation.

Evolution: consistent: social media amplification continues on schedule with the post-announcement pattern; German-language coverage (KI News Daily) adds international reach; drug discovery linkage adds a new narrative extension

[150][151][152][153][154][155][156][157][158][159][160][161][162][80][83][22][23][24][25]

AI medical scribe market (AWS HealthScribe, Nuance DAX, Freed, DeepCura, Clinically AI)

A mature, distinct market for documentation assistance AI operates in a separate category from diagnostic consultation AI, but Abridge's UpToDate partnership deepens its cross-over into evidence-backed decision support, blurring the category boundary.

Evolution: consistent: no new scribe market developments in current items

[163][164][165][166][167][168][169][170][68]

Tensions

  • Benchmark performance vs. real-world clinical safety: the AI co-clinician achieved strong scores in controlled simulations — including reported outperformance of GPT-5.4 — but underperformed physicians specifically in identifying red flags and guiding physical examinations, the safety-critical skills most consequential in actual clinical settings. [26][171][172][9]
  • Research trial vs. deployed scale: DeepMind's co-clinician is in the research-to-trial transition with the Included Health nationwide randomized study, while OpenEvidence has documented 1 million physician-AI clinical consultations in a single 24-hour period and reached a $12 billion valuation confirmed by Reuters — creating a scale and capital gap the randomized trial design cannot close in the near term. [26][173][34][174][43][45][46][49][39][53][57][5]
  • AI and clinical skill development in trainees — competing empirical positions: previously documented systematic reviews suggest AI adoption during training may impair clinical skill acquisition and independent reasoning, while ABMS now argues AI may enhance clinical skills and competence — the question has moved from an emerging concern to an actively contested empirical debate with institutional certification stakes on both sides. [140][142][143][144][145][139][15][16][11][10][13][14][26]
  • US vs. EU regulatory gap with a concrete deadline: FDA is moving toward simplified AI medical device approval but has not applied its framework to conversational diagnostic AI; the EU AI Act's August 2026 compliance deadline for medtech companies creates a near-term forcing function Google has not publicly addressed. [175][176][177][178][179][126][128][107][108][109][110][129][130][131]
  • Patient transparency and consent — from academic frameworks to malpractice exposure: triadic care assumes patient awareness of AI involvement, but Stanford Law argues existing disclosure frameworks fail on their own terms, Harvard Petrie-Flom Center argues AI is redefining consent rules, and Medical Economics frames the question as active malpractice liability for practicing physicians — converting an academic debate into a clinical risk management question. [180][181][182][132][133][134][135][136][137][119][138][93]
  • Competitive differentiation in a converging market: Abridge's NEJM, JAMA, and UpToDate partnerships deepen its cross-over into consultation territory; OpenEvidence's DeepConsult mirrors DeepMind's physician-agent architecture at superior scale; Glass Health competes with Abridge on scribing at early-stage scale; and Epic's Agent Factory introduces configurable AI agent workflows from the EHR incumbent — DeepMind has not articulated what architecturally or clinically distinguishes the co-clinician from any of these competitors. [97][98][99][100][101][183][163][164][166][167][169][170][43][60][46][68][52][8][7][19]
  • Physician leadership vs. industry-led AI deployment: the AMA's position that 'physicians must lead in developing AI tools' and MGMA's 'rules for the humans in the loop' governance framing both sit in tension with a model where major tech companies (Google, Amazon, Microsoft, Epic) design the architecture, benchmarks, and deployment partnerships — with 80%+ physician AI adoption now mainstream, the governance question is who controls the design. [75][76][79][26][33][80][94][96][92]
  • 'AI teammate' vs. 'AI doctor' branding: multiple social commentators analyze DeepMind's choice of 'co-clinician' over 'AI doctor' as a deliberate framing decision — raising the question of whether the naming obscures rather than resolves the autonomy questions at stake, particularly as OpenEvidence's DeepConsult operates at 1M-consultation scale without the same framing caution. [160][161][184][162][185][43][46]
  • 2026 as evidentiary inflection year: JAMA calls for new research on AI in medicine and has framed 2026 as potentially 'the year of real-world evidence,' while PHTI adds a policy layer — what evidence standard must be met before scaling adoption — and the ARISE clinical AI report documents sector boom without resolving whether scale or rigor constitutes proof that AI improves patient outcomes. [43][60][71][34][84][39][86][186][91][73][74][17]
  • Same-day competitive narrative fragmentation: Microsoft's global healthcare AI report and Amazon's One Medical Health AI assistant launch both appeared on April 30, 2026 — the same day as DeepMind's co-clinician announcement — raising the question of whether DeepMind can establish distinctive narrative ownership in an environment where every major tech company is simultaneously announcing healthcare AI progress. [94][102][96][26][35]
  • Trust measurement gap in clinical AI: an arXiv preprint argues clinical AI systems must move from opaque black-box confidence scores to measurable, auditable trust metrics — a technical challenge that sits beneath the regulatory and clinical validation debates and that neither the co-clinician's published benchmarks nor the EU AI Act's compliance requirements have yet operationally resolved. [18][26][126][128]

Sources

  1. [1] Glass Health Raises $5M for AI-Powered Clinical Decision Support Platform | Y Combinator | 13 comments — reactive:deepmind-ai-co-clinician
  2. [2] Glass Health: AI-Powered Clinical Decision Support Company ... — reactive:deepmind-ai-co-clinician
  3. [3] Glass Health | Ambient Scribing & Clinical Decision Support — reactive:deepmind-ai-co-clinician
  4. [4] Glass Health: AI-Powered Clinical Decision Support & Ambient Scribing | Y Combinator — reactive:deepmind-ai-co-clinician
  5. [5] Medical AI startup OpenEvidence doubles valuation to $12 billion in ... — reactive:deepmind-ai-co-clinician
  6. [6] Thunderstruck By OpenEvidence’s $12B Valuation? Don’t Be.  - MedCity News — reactive:deepmind-ai-co-clinician
  7. [7] Glass Health vs Abridge AI: 2026 Scribe & CDS Comparison — reactive:deepmind-ai-co-clinician
  8. [8] Glass Health Review — Clinical AI Report | Clinical AI Report — reactive:deepmind-ai-co-clinician
  9. [9] Google DeepMind's AI co-clinician outpaces GPT-5.4, but doctors ... — reactive:deepmind-ai-co-clinician
  10. [10] AI May Enhance Clinical Skills, Competence | American Board of Medical Specialties — reactive:deepmind-ai-co-clinician
  11. [11] How can medical trainees use AI without losing critical thinking skills? — reactive:deepmind-ai-co-clinician
  12. [12] Opportunities and Risks of AI for Precision Medical Education - CLIME — reactive:deepmind-ai-co-clinician
  13. [13] Curriculum and Educational Implications of AI - The Hospitalist — reactive:deepmind-ai-co-clinician
  14. [14] AI-Enabled Precision-Education Systems — Transforming Lifelong ... — reactive:deepmind-ai-co-clinician
  15. [15] AI in medical student education | AMEP | Dove Medical Press — reactive:deepmind-ai-co-clinician
  16. [16] AI Use for Medical Students: Impact on Clinical Skill Acquisition and ... — reactive:deepmind-ai-co-clinician
  17. [17] Clinical AI: Evidence and Policy Requirements for Scaling Adoption — reactive:deepmind-ai-co-clinician
  18. [18] From Black-Box Confidence to Measurable Trust in Clinical AI - arXiv — reactive:deepmind-ai-co-clinician
  19. [19] Epic Unveils Agent Factory & Expands ... — reactive:deepmind-ai-co-clinician
  20. [20] ARISE Releases 2026 State of Clinical AI Report | Ethan Goh, MD posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  21. [21] ARISE Maps the State of Clinical AI — reactive:deepmind-ai-co-clinician
  22. [22] AI co-clinician: researching the path toward AI-augmented care | Google DeepMind — reactive:deepmind-ai-co-clinician (2026-05-02)
  23. [23] https://t.co/JarrlxEhJ6 — reactive:deepmind-ai-co-clinician (2026-05-02)
  24. [24] #TECH: 🌐Google DeepMind Unveils AI Co Clinician as Drug Discovery Push Nears Human Trials — reactive:deepmind-ai-co-clinician (2026-05-02)
  25. [25] DeepMind bringt 'AI co‑clinician': KI hilft dir und Ärzt:innen in Praxis & Telemedizin, bleibt Assistenz — Blindtest... — reactive:deepmind-ai-co-clinician (2026-05-02)
  26. [26] Enabling a new model for healthcare with AI co-clinician — DeepMind Blog (2026-04-30)
  27. [27] researching the path toward AI-augmented care | Pushmeet Kohli — reactive:deepmind-ai-co-clinician
  28. [28] Google DeepMind AI coscientist system validated by lab experiments | Alan Karthikesalingam MD PhD posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  29. [29] Google Research Collaborates with DeepMind on Multi-Agent ... — reactive:deepmind-ai-co-clinician
  30. [30] Dr. Vivek Natarajan, Research Scientist at Google DeepMind/Health ... — reactive:deepmind-ai-co-clinician
  31. [31] Today, Google is announcing a strategic partnership with Included Health to collaborate on a nationwide randomized study of AI in virtual care. AI systems capable of clinical reasoning and dialogue… | Mike Schäkermann | 19 comments — reactive:deepmind-ai-co-clinician
  32. [32] Google Partnership to Pilot New Offering in Outpatient Care Setting | TechTarget — reactive:deepmind-ai-co-clinician
  33. [33] Enabling physician-centered oversight for AMIE - Google Research — reactive:deepmind-ai-co-clinician
  34. [34] Collaborating on a nationwide randomized study of AI in real-world virtual care — reactive:deepmind-ai-co-clinician
  35. [35] AI co-clinician is our new research initiative to help explore how ... — reactive:deepmind-ai-co-clinician
  36. [36] Health AI — Google AI — reactive:deepmind-ai-co-clinician
  37. [37] MedGemma 1.5 Technical Report - arXiv — reactive:deepmind-ai-co-clinician
  38. [38] Next generation medical image interpretation with MedGemma 1.5 and medical speech to text with MedASR — reactive:deepmind-ai-co-clinician
  39. [39] In partnership with Included Health, we will be launching a first-of-its ... — reactive:deepmind-ai-co-clinician
  40. [40] Enabling a new model for healthcare with AI co-clinician — reactive:deepmind-ai-co-clinician (2026-05-01)
  41. [41] MedGemma Technical Report - arXiv — reactive:deepmind-ai-co-clinician
  42. [42] MedGemma: Our most capable open models for health AI development — reactive:deepmind-ai-co-clinician
  43. [43] AI Collaborates with Physicians in 1M Clinical Consultations in 24 Hours | OpenEvidence posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  44. [44] AI Reshaping Clinical Decision-Making: OpenEvidence’s 2026 Strategic Outlook and Implications for the Greater Bay Area — reactive:deepmind-ai-co-clinician
  45. [45] OpenEvidence Doubles Valuation to $12bn as Physician Adoption Accelerates — reactive:deepmind-ai-co-clinician
  46. [46] OpenEvidence, the Fastest-Growing Application for Physicians in History, Announces $210 Million Round at $3.5 Billion Valuation: OpenEvidence also announces the wide release of OpenEvidence DeepConsult™—the first AI agent purpose-built for physicians | OpenEvidence — reactive:deepmind-ai-co-clinician
  47. [47] The Clinical AI Landscape in 2026: ChatGPT, OpenEvidence, iatroX, Medwise, and What Comes Next | iatroX Clinical AI Insights — reactive:deepmind-ai-co-clinician
  48. [48] OpenEvidence Review — Clinical AI Report | Clinical AI Report — reactive:deepmind-ai-co-clinician
  49. [49] OpenEvidence Achieves Historic Milestone: 1 Million Clinical ... — reactive:deepmind-ai-co-clinician
  50. [50] OpenEvidence revenue, valuation & funding - Sacra — reactive:deepmind-ai-co-clinician
  51. [51] How OpenEvidence AI is transforming clinical decision-making — reactive:deepmind-ai-co-clinician
  52. [52] OpenEvidence vs Glass Health: 2026 Comparison for Physicians | Clinical AI Report — reactive:deepmind-ai-co-clinician
  53. [53] OpenEvidence Achieves Historic Milestone: 1 Million Clinical Consultations between Verified Doctors and an Artificial Intelligence System in a Single Day — reactive:deepmind-ai-co-clinician
  54. [54] Deep Consult | User Guide | OpenEvidence — reactive:deepmind-ai-co-clinician
  55. [55] OpenEvidence — reactive:deepmind-ai-co-clinician
  56. [56] Daniel Nadler on OpenEvidence: Doctors' Favorite AI App — reactive:deepmind-ai-co-clinician
  57. [57] OpenEvidence Achieves Historic Milestone: 1 Million Clinical ... — reactive:deepmind-ai-co-clinician
  58. [58] Glass Health - 2026 Company Profile, Team, Funding & Competitors — reactive:deepmind-ai-co-clinician
  59. [59] Glass Health 2026 Company Profile: Valuation, Funding & Investors — reactive:deepmind-ai-co-clinician
  60. [60] Abridge Partners with NEJM and JAMA for AI Clinical Decision-Making — reactive:deepmind-ai-co-clinician
  61. [61] Abridge Integrates Peer-Reviewed Evidence with NEJM & JAMA — reactive:deepmind-ai-co-clinician
  62. [62] Why Abridge is Embedding NEJM and JAMA Directly into the EHR — reactive:deepmind-ai-co-clinician
  63. [63] Abridge partners with medical journals to expand AI clinical decision support | Healthcare Dive — reactive:deepmind-ai-co-clinician
  64. [64] Abridge incorporates more clinical evidence into its decision support tools | Healthcare IT News — reactive:deepmind-ai-co-clinician
  65. [65] Partnership for clinical decision support moves AI to next level — reactive:deepmind-ai-co-clinician
  66. [66] Abridge to Bring NEJM & JAMA into Clinical Conversations — reactive:deepmind-ai-co-clinician
  67. [67] Abridge Partners with NEJM and JAMA to Integrate Peer-Reviewed ... — reactive:deepmind-ai-co-clinician
  68. [68] Abridge expands CDS with UpToDate, new content integrations — reactive:deepmind-ai-co-clinician
  69. [69] Abridge Clinical Decision Support | Evidence Shaped by Your Conversation — reactive:deepmind-ai-co-clinician
  70. [70] Epic Releases Native AI Charting for Integrated Clinical ... - HLTH — reactive:deepmind-ai-co-clinician
  71. [71] Will 2026 be the year of real-world evidence that #AI can actually ... — reactive:deepmind-ai-co-clinician
  72. [72] Considerations in Translating AI to Improve Care - JAMA Network — reactive:deepmind-ai-co-clinician
  73. [73] JAMA — reactive:deepmind-ai-co-clinician
  74. [74] AI, Health, and Health Care Today and Tomorrow - JAMA Network — reactive:deepmind-ai-co-clinician
  75. [75] AMA: Physicians' use of AI doubled from 2023 to 2026 — reactive:deepmind-ai-co-clinician
  76. [76] [PDF] 2026 Physician Survey on Augmented Intelligence — reactive:deepmind-ai-co-clinician
  77. [77] Feb. 27, 2026: National Advocacy Update — reactive:deepmind-ai-co-clinician
  78. [78] Physician Survey on Augmented Intelligence | American Medical Association — reactive:deepmind-ai-co-clinician
  79. [79] AMA: Physicians must lead in developing AI tools to improve patient ... — reactive:deepmind-ai-co-clinician
  80. [80] More than 80% of physicians use AI professionally: AMA survey | American Medical Association — reactive:deepmind-ai-co-clinician
  81. [81] AI, Health Care, and What to Expect in 2026 - AMA Ed Hub — reactive:deepmind-ai-co-clinician
  82. [82] AMA Survey Finds Rapid Growth in Physician AI Adoption - The ASCO Post — reactive:deepmind-ai-co-clinician
  83. [83] AI in medicine is moving fast—and physicians are already putting it ... — reactive:deepmind-ai-co-clinician
  84. [84] Clinical AI Has Boomed. A New Stanford-Harvard State of Clinical AI ... — reactive:deepmind-ai-co-clinician
  85. [85] Stanford-Harvard Report on Clinical AI in 2026 | Moritz Hartmann posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  86. [86] State of Clinical AI Report 2026 - ARISE — reactive:deepmind-ai-co-clinician
  87. [87] Clinical AI Enters a New Phase, Stanford–Harvard Report Finds - BABL AI — reactive:deepmind-ai-co-clinician
  88. [88] [PDF] State of Clinical AI Report 2026 - Public Services Alliance — reactive:deepmind-ai-co-clinician
  89. [89] Dr Lucinda Scharff's Post - State of Clinical AI Report 2026 - LinkedIn — reactive:deepmind-ai-co-clinician
  90. [90] Jonas Verbeke - State of Clinical AI Report 2026 - LinkedIn — reactive:deepmind-ai-co-clinician
  91. [91] Medicine | The 2026 AI Index Report | Stanford HAI — reactive:deepmind-ai-co-clinician
  92. [92] AI governance in medical group practices: Rules for the humans in the loop — reactive:deepmind-ai-co-clinician
  93. [93] Inside AI malpractice law: Should physicians disclose when AI is used in care? | Medical Economics — reactive:deepmind-ai-co-clinician
  94. [94] Big Tech Enters Healthcare with Amazon Health, Microsoft Copilot ... — reactive:deepmind-ai-co-clinician
  95. [95] AI Solutions Optimized for Epic | Microsoft for Healthcare — reactive:deepmind-ai-co-clinician
  96. [96] AI Transformation Accelerates Progress in Healthcare Services for ... — reactive:deepmind-ai-co-clinician
  97. [97] Randomized Trial Protocol: Epic Generative AI Chart Summarization Tool to Reduce Ambulatory Provider Cognitive Task Load | medRxiv — reactive:deepmind-ai-co-clinician
  98. [98] Amazon's Healthcare AI vs. Everyone Else: Who Will Own the Doctor's Office in 2026? | AI Magicx Blog | AI Magicx — reactive:deepmind-ai-co-clinician
  99. [99] Epic AI Charting 2026: What Healthcare Providers Need to Know | SOAPNoteAI - SOAP Note Guides and Examples — reactive:deepmind-ai-co-clinician
  100. [100] Amazon makes a new bet on healthcare AI, rivaling Microsoft in the doctor's office – GeekWire — reactive:deepmind-ai-co-clinician
  101. [101] Amazon Scales Health AI Assistant to All US Customers — reactive:deepmind-ai-co-clinician
  102. [102] Today, we're excited to introduce the new Amazon One Medical ... — reactive:deepmind-ai-co-clinician
  103. [103] Epic's AI Scribe: Impact on Ambient Market and Predictions | Joshua Liu posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  104. [104] Amazon's move to get out ahead in health AI agent race — reactive:deepmind-ai-co-clinician
  105. [105] Amazon launches healthcare AI assistant on its website, app - Reuters — reactive:deepmind-ai-co-clinician
  106. [106] FDA Approval of Artificial Intelligence and Machine Learning ... - PMC — reactive:deepmind-ai-co-clinician
  107. [107] FDA finalizes recommendations simplifying approval process for medical devices that use AI | AHA News — reactive:deepmind-ai-co-clinician
  108. [108] Artificial Intelligence in Clinical Decision-Making: Regulatory Roadmap and Reimbursement Strategies | Akin Gump Strauss Hauer & Feld LLP - JDSupra — reactive:deepmind-ai-co-clinician
  109. [109] Artificial Intelligence in Software as a Medical Device - FDA — reactive:deepmind-ai-co-clinician
  110. [110] Artificial Intelligence-Enabled Medical Devices - FDA — reactive:deepmind-ai-co-clinician
  111. [111] Considerations for the Use of Artificial Intelligence - FDA — reactive:deepmind-ai-co-clinician
  112. [112] Journal of Medical Internet Research - AI Act Compliance Within the MyHealth@EU Framework: Tutorial — reactive:deepmind-ai-co-clinician
  113. [113] European Commission consultation shapes high-risk AI classification for life sciences in the EU | Osborne Clarke — reactive:deepmind-ai-co-clinician
  114. [114] Balancing Innovation and Control: The European Union AI Act ... — reactive:deepmind-ai-co-clinician
  115. [115] The EU AI Act & Pharma: Compliance Guide + Flowchart | IntuitionLabs — reactive:deepmind-ai-co-clinician
  116. [116] EU Commission Consultation on High-Risk AI Systems — reactive:deepmind-ai-co-clinician
  117. [117] AI in Clinical Trials & Compliance with the EU AI Act — reactive:deepmind-ai-co-clinician
  118. [118] Artificial Intelligence in healthcare — reactive:deepmind-ai-co-clinician
  119. [119] Article 6: Classification Rules for High-Risk AI Systems | EU Artificial Intelligence Act — reactive:deepmind-ai-co-clinician
  120. [120] Annex III: High-Risk AI Systems Referred to in Article 6(2) - EU AI Act — reactive:deepmind-ai-co-clinician
  121. [121] How the EU AI Act Affects Clinical Trials — reactive:deepmind-ai-co-clinician
  122. [122] EU AI Act Compliance: Annex III Extension Guide 2024 — reactive:deepmind-ai-co-clinician
  123. [123] EU AI Act for Medical Devices: SaMD Compliance ... - MDx CRO — reactive:deepmind-ai-co-clinician
  124. [124] High-Risk AI Systems Under the EU AI Act - DPO Consulting — reactive:deepmind-ai-co-clinician
  125. [125] High-Risk AI Systems: Strict Compliance Obligations You Need to ... — reactive:deepmind-ai-co-clinician
  126. [126] EU AI Act and Medical Devices: Compliance Guide 2026 — reactive:deepmind-ai-co-clinician
  127. [127] [PDF] Conformity Assessments under the EU AI Act: A step-by step guide — reactive:deepmind-ai-co-clinician
  128. [128] Implementation Timeline | EU Artificial Intelligence Act — reactive:deepmind-ai-co-clinician
  129. [129] The EU AI Act in Healthcare: From compliance to competitive edge — reactive:deepmind-ai-co-clinician
  130. [130] EU AI Act – What are the obligations for “high-risk AI systems”? — reactive:deepmind-ai-co-clinician
  131. [131] Complete Guide to EU AI Act High-Risk Classification | EU AI Act Resources | EU AI Risk — reactive:deepmind-ai-co-clinician
  132. [132] The Emerging Therapeutic Triad: How AI Complicates Informed ... — reactive:deepmind-ai-co-clinician
  133. [133] Artificial intelligence and the law of informed consent - Research Handbook on Health, AI and the Law - NCBI Bookshelf — reactive:deepmind-ai-co-clinician
  134. [134] The use of #AI tools in health care raises questions about patient ... — reactive:deepmind-ai-co-clinician
  135. [135] Patient Consent and The Right to Notice and Explanation of AI ... — reactive:deepmind-ai-co-clinician
  136. [136] Notification and Consent Preferences Based on U.S. National Survey — reactive:deepmind-ai-co-clinician
  137. [137] Consent All the Way Down: What Healthcare AI Disclosure Inherits from Privacy Law - CodeX - Stanford Law School — reactive:deepmind-ai-co-clinician
  138. [138] Informed Consent, Redefined: How AI and Big Data Are Changing the Rules - Petrie-Flom Center — reactive:deepmind-ai-co-clinician
  139. [139] Google DeepMind AI co-clinician : r/medicalschool - Reddit — reactive:deepmind-ai-co-clinician
  140. [140] Utilization of AI Among Medical Students and Development of AI ... — reactive:deepmind-ai-co-clinician
  141. [141] How Medical Teaching Will Look in 2026 with AI Driven Platforms — reactive:deepmind-ai-co-clinician
  142. [142] Medical students perceptions and attitudes toward the use of ... — reactive:deepmind-ai-co-clinician
  143. [143] AI Use for Medical Students: Impact on Clinical Skill Acquisition and ... — reactive:deepmind-ai-co-clinician
  144. [144] Attitudes of medical and life sciences university students ... - Nature — reactive:deepmind-ai-co-clinician
  145. [145] AI Use for Medical Students: Impact on Clinical Skill Acquisition and ... — reactive:deepmind-ai-co-clinician
  146. [146] [PDF] Awareness and Attitude Toward Artificial Intelligence Among ... — reactive:deepmind-ai-co-clinician
  147. [147] Integrating artificial intelligence into medical education: a roadmap ... — reactive:deepmind-ai-co-clinician
  148. [148] Why AI in Medical Education Needs a 2026 Strategy — reactive:deepmind-ai-co-clinician
  149. [149] Artificial intelligence in medicine: a scoping review of the risk of ... — reactive:deepmind-ai-co-clinician
  150. [150] Google DeepMind Launches AI Co-Clinician - YouTube — reactive:deepmind-ai-co-clinician
  151. [151] Big week for AI: 🤖 — reactive:deepmind-ai-co-clinician (2026-05-02)
  152. [152] 🩺 Doctor + AI + Patient — reactive:deepmind-ai-co-clinician (2026-05-01)
  153. [153] Alan takes a deep dive into this remarkable new AI co-clinician from Google DeepMind. — reactive:deepmind-ai-co-clinician (2026-05-01)
  154. [154] Google DeepMind's AI co-clinician research is a reminder that the next healthcare AI wave may not replace doctors. It ma... — reactive:deepmind-ai-co-clinician (2026-05-01)
  155. [155] OpenAI introduces Advanced Account Security, DeepMind AI co-clinician | Next in AI | Astha La Vista #ai #artificialint... — reactive:deepmind-ai-co-clinician (2026-05-01)
  156. [156] AI News – May 1, 2026 — reactive:deepmind-ai-co-clinician (2026-05-01)
  157. [157] Google DeepMind's AI clinician aims to aid doctors | StartupHub.ai — reactive:deepmind-ai-co-clinician
  158. [158] AI co-clinician is our new research initiative to help explore how ... — reactive:deepmind-ai-co-clinician
  159. [159] AI co-clinician: enabling a new model for healthcare | Vishnu Ravi, MD — reactive:deepmind-ai-co-clinician
  160. [160] Google DeepMind isn’t building an AI doctor — it’s giving doctors an AI teammate. — reactive:deepmind-ai-co-clinician (2026-05-01)
  161. [161] Google DeepMind chamou de "co-clinician", não de "AI doctor" ou "diagnostic agent". — reactive:deepmind-ai-co-clinician (2026-05-01)
  162. [162] Google DeepMind's AI co-clinician runs live video with patients, guides physical exams in real time, and defers to physi... — reactive:deepmind-ai-co-clinician (2026-05-01)
  163. [163] Compare AWS HealthScribe vs. Clinically AI in 2026 — reactive:deepmind-ai-co-clinician
  164. [164] 2026 AI Medical Scribe Comparison: Top Tools for Clinicians | Twofold Health posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  165. [165] Healthcare AI Platforms: AWS vs Microsoft vs Google 2026 — reactive:deepmind-ai-co-clinician
  166. [166] Top AI Medical Scribe Companies in 2026 | Accuracy & Comparison — reactive:deepmind-ai-co-clinician
  167. [167] 15 Best AI Medical Scribes in 2026 (Ranked & Compared) - DeepCura — reactive:deepmind-ai-co-clinician
  168. [168] AWS HealthScribe vs. Clinically AI Comparison - SourceForge — reactive:deepmind-ai-co-clinician
  169. [169] 9 Best AI Scribes [2026] Comparisons, Benefits, Features, and More — reactive:deepmind-ai-co-clinician
  170. [170] 5 Best AI Medical Scribe Tools for 2026: In-Depth Comparison - Reddit — reactive:deepmind-ai-co-clinician
  171. [171] Google DeepMind’s real-time video AI doctor is here. — Rohan Paul Twitter (2026-04-30)
  172. [172] 🔴 DeepMind AI co-clinician: 98 blind-eval queries — doctors preferred it. 97/98 zero critical errors. — reactive:deepmind-ai-co-clinician (2026-05-01)
  173. [173] Google to evaluate conversational AI in virtual care — reactive:deepmind-ai-co-clinician
  174. [174] Google Research Partners with Included Health on Nationwide AI ... — reactive:deepmind-ai-co-clinician
  175. [175] Understanding FDA regulations for AI in SaMD | ICON plc — reactive:deepmind-ai-co-clinician
  176. [176] FDA Clearance & Clinical Adoption for AI Diagnostics | Bot Image — reactive:deepmind-ai-co-clinician
  177. [177] AI for Medical Device Regulation (FDA): Accelerating Approval Pathways - PPLE Labs — reactive:deepmind-ai-co-clinician
  178. [178] Demystifying Regulatory Hurdles: How to Navigate FDA Approval for ... — reactive:deepmind-ai-co-clinician
  179. [179] How to Get your AI models FDA approved: AI/ML Regulatory Landscape | Encord — reactive:deepmind-ai-co-clinician
  180. [180] 66% of US doctors now use AI in your care — often without saying ... — reactive:deepmind-ai-co-clinician
  181. [181] When AI is in the room: rethinking the medical conversation | InSight+ — reactive:deepmind-ai-co-clinician
  182. [182] AI is a 'third party' in the consultation room, say experts - BMJ Group — reactive:deepmind-ai-co-clinician
  183. [183] AI co-clinician from DeepMind will start a new product war provoking OpenEvidence, DoximityGPT, ChatGPT for Clinicians, ... — reactive:deepmind-ai-co-clinician (2026-05-01)
  184. [184] Google Deepmind just announced an AI that sits in the exam room with your doctor. — reactive:deepmind-ai-co-clinician (2026-05-01)
  185. [185] 醫院 AI 不再叫「工具」，改名「聯合醫師」。 — reactive:deepmind-ai-co-clinician (2026-05-01)
  186. [186] The 2026 AI Index Report | Stanford HAI — reactive:deepmind-ai-co-clinician
  187. [187] AI assistant for doctors? Google DeepMind working on AI model that ... — reactive:deepmind-ai-co-clinician
  188. [188] MedGemma 1.5 model card | Health AI Developer Foundations — reactive:deepmind-ai-co-clinician
  189. [189] MedGemma 1.5: Mastering 3D Medical Imaging and EHR Analysis — reactive:deepmind-ai-co-clinician
  190. [190] [2604.05081] MedGemma 1.5 Technical Report - arXiv — reactive:deepmind-ai-co-clinician
  191. [191] (PDF) MedGemma 1.5 Technical Report - ResearchGate — reactive:deepmind-ai-co-clinician
  192. [192] MedGemma 1.5: Run Medical AI on Your Own Servers - medgemma.pro — reactive:deepmind-ai-co-clinician
  193. [193] MedGemma 1.5 Extends Google's Open Model for Healthcare AI ... — reactive:deepmind-ai-co-clinician
  194. [194] MedGemma: Advanced AI Models for Medical Text and Image ... — reactive:deepmind-ai-co-clinician
  195. [195] Revolutionizing Healthcare: How Google DeepMind is Transforming ... — reactive:deepmind-ai-co-clinician
  196. [196] Google DeepMind launches AI co-clinician research program with multimodal AI agent | KuCoin — reactive:deepmind-ai-co-clinician
  197. [197] Google DeepMind Launches AI Co-Clinician Initiative — reactive:deepmind-ai-co-clinician
  198. [198] Google Deepmind launches AI Co-Clinician initiative - Reddit — reactive:deepmind-ai-co-clinician
  199. [199] Wow, this is so cool! Real-time AI doctor, via video, from Google ... — reactive:deepmind-ai-co-clinician
  200. [200] Google DeepMind deklassiert mit dem AI co-clinician GPT-5.4 im Medizin-Benchmark. Ein multimodales KI-Modell für Live-Te... — reactive:deepmind-ai-co-clinician (2026-04-30)
  201. [201] @AudioBooksRU @GoogleDeepMind @harvardmed @StanfordMed You're right—the demo shows the AI co-clinician directly intervie... — reactive:deepmind-ai-co-clinician (2026-04-30)
  202. [202] AI co-clinician: researching the path toward AI-augmented care — Google DeepMind https://t.co/6qXLmCd8Av — reactive:deepmind-ai-co-clinician (2026-04-30)
  203. [203] AI co-clinician: researching the path toward AI-augmented care - Google DeepMind https://t.co/JA2TobQ7jS — reactive:deepmind-ai-co-clinician (2026-04-30)
  204. [204] This AI co-clinician from Google DeepMind aced 97 out of 98 clinical tests — reactive:deepmind-ai-co-clinician (2026-04-30)
  205. [205] Google DeepMindが『AI co-clinician』を発表。マルチモーダルエージェントが医療現場をサポート。医療従事者とAIの協働で課題解決へ。ぼくも注視中。 by トウマ — reactive:deepmind-ai-co-clinician (2026-04-30)
  206. [206] Google DeepMind、医師を支援する AI co-clinician を発表🏥🤖 臨床エビデンス統合で 98 件中 97 件を正確に処理。テレメディシンでは一次医療医と同等のパフォーマンス。WHO が指摘する医療労働者 1000 ... — reactive:deepmind-ai-co-clinician (2026-04-30)
  207. [207] Excited to see DeepMind's AI co‑clinician initiative advancing multimodal support. To deliver value on healthcare teams... — reactive:deepmind-ai-co-clinician (2026-04-30)
  208. [208] NEWS: Google DeepMind announces AI co-clinician for healthcare. — reactive:deepmind-ai-co-clinician (2026-04-30)
  209. [209] Google Deepmind dropped ai co clinician research today — reactive:deepmind-ai-co-clinician (2026-04-30)
  210. [210] Google DeepMind unveils AI co-clinician. — reactive:deepmind-ai-co-clinician (2026-04-30)
  211. [211] NEWS: Google DeepMind launches an AI co-clinician research project to explore how multimodal agents can assist healthcar... — reactive:deepmind-ai-co-clinician (2026-04-30)
  212. [212] Google DeepMind just dropped an AI co-clinician 🤖 — reactive:deepmind-ai-co-clinician (2026-04-30)
  213. [213] Google DeepMind Just Solved a Major Problem with AI Doctors — reactive:deepmind-ai-co-clinician
  214. [214] 2026年4月30日、Google DeepMindが「AI co-clinician: researching the path toward AI-augmented care」を公開しました。臨床推論や診療判断を補助するAI共同臨床医... — reactive:deepmind-ai-co-clinician (2026-04-30)
  215. [215] BREAKING: google deepmind publishes research on an ai co-clinician model for healthcare. https://t.co/8uNF4AewKw — reactive:deepmind-ai-co-clinician (2026-04-30)
  216. [216] Google DeepMind's real-time video AI doctor is here. They just ... — reactive:deepmind-ai-co-clinician
  217. [217] AI co-clinician is Google DeepMind's new research initiative to help ... — reactive:deepmind-ai-co-clinician
  218. [218] Google Partners with Included Health on Nationwide AI in Virtual ... — reactive:deepmind-ai-co-clinician
  219. [219] الوضع صار اكثر جديه الان وممتع 😅 — reactive:deepmind-ai-co-clinician (2026-05-01)
  220. [220] Google DeepMind's AI co-clinician research is another signal that ... — reactive:deepmind-ai-co-clinician